首页> 外国专利> Compound 3-(5-amine-2-methyl-4-Oxo-4H-Quinazolin-3-IL) -Piperidin-2,6-dioxin; Pharmaceutical synthesis containing this substance; and its use in treating or preventing diseases or disorders such as cancer, angiography, pain, pulmonary and gastric disorders SNC.

Compound 3-(5-amine-2-methyl-4-Oxo-4H-Quinazolin-3-IL) -Piperidin-2,6-dioxin; Pharmaceutical synthesis containing this substance; and its use in treating or preventing diseases or disorders such as cancer, angiography, pain, pulmonary and gastric disorders SNC.

机译:化合物3-(5-胺-2-甲基-4-氧代-4H-喹唑啉-3-IL)-哌啶-2,6-二恶英;含有该物质的药物合成;及其在治疗或预防疾病或病症中的用途,例如癌症,血管造影,疼痛,肺和胃疾病SNC。

摘要

Disclosed is a solid form of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione: or a stereoisomer thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, or clathrate thereof, having an X-ray powder diffraction pattern substantially as shown in FIG. 1; or having an X-ray powder diffraction pattern comprising peaks at about 14.6, 15.6, 16.7, 21.9 and 30.0 degrees 2¸, optionally having an X-ray powder diffraction pattern comprising peaks at about 9.2, 13.4, 14.0, 14.6, 15.6, 16.7, 18.5, 21.9, 22.7, 24.8, 28.1, 30.0 and 37.0 degrees 2¸.
机译:公开了3-(5-氨基-2-甲基-4-氧代-4H-喹唑啉-3-基)-哌啶-2,6-二酮的固体形式:或其立体异构体,或其药学上可接受的盐,溶剂化物,水合物,共晶体或包合物,其具有基本上如图1所示的X射线粉末衍射图。 1;或具有X射线粉末衍射图样,其峰值在约14.6、15.6、16.7、21.9和30.0度20.0处,可选地具有X射线粉末衍射图样的峰值在约9.2、13.4、14.0、14.6、15.6、16.7处,18.5、21.9、22.7、24.8、28.1、30.0和37.0度2°。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号